Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 10 |
GO:0110165 | cellular anatomical entity | 1 | 10 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005811 | lipid droplet | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: E9B580
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 13 |
GO:0008152 | metabolic process | 1 | 13 |
GO:0009056 | catabolic process | 2 | 13 |
GO:0016042 | lipid catabolic process | 4 | 13 |
GO:0044238 | primary metabolic process | 2 | 13 |
GO:0071704 | organic substance metabolic process | 2 | 13 |
GO:1901575 | organic substance catabolic process | 3 | 13 |
GO:0006638 | neutral lipid metabolic process | 4 | 1 |
GO:0006639 | acylglycerol metabolic process | 5 | 1 |
GO:0006641 | triglyceride metabolic process | 6 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0019433 | triglyceride catabolic process | 7 | 1 |
GO:0042592 | homeostatic process | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044242 | cellular lipid catabolic process | 4 | 1 |
GO:0044248 | cellular catabolic process | 3 | 1 |
GO:0044255 | cellular lipid metabolic process | 3 | 1 |
GO:0046461 | neutral lipid catabolic process | 5 | 1 |
GO:0046464 | acylglycerol catabolic process | 6 | 1 |
GO:0046486 | glycerolipid metabolic process | 4 | 1 |
GO:0046503 | glycerolipid catabolic process | 5 | 1 |
GO:0048878 | chemical homeostasis | 4 | 1 |
GO:0055088 | lipid homeostasis | 5 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0065008 | regulation of biological quality | 2 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 13 |
GO:0016787 | hydrolase activity | 2 | 13 |
GO:0004806 | triglyceride lipase activity | 5 | 1 |
GO:0016298 | lipase activity | 4 | 1 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 1 |
GO:0052689 | carboxylic ester hydrolase activity | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 277 | 281 | PF00656 | 0.410 |
CLV_NRD_NRD_1 | 121 | 123 | PF00675 | 0.459 |
CLV_NRD_NRD_1 | 400 | 402 | PF00675 | 0.547 |
CLV_PCSK_KEX2_1 | 73 | 75 | PF00082 | 0.486 |
CLV_PCSK_PC1ET2_1 | 73 | 75 | PF00082 | 0.491 |
CLV_PCSK_SKI1_1 | 146 | 150 | PF00082 | 0.562 |
CLV_PCSK_SKI1_1 | 283 | 287 | PF00082 | 0.636 |
CLV_PCSK_SKI1_1 | 336 | 340 | PF00082 | 0.361 |
CLV_PCSK_SKI1_1 | 364 | 368 | PF00082 | 0.361 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.469 |
DEG_SPOP_SBC_1 | 11 | 15 | PF00917 | 0.578 |
DOC_MAPK_gen_1 | 283 | 291 | PF00069 | 0.466 |
DOC_MAPK_gen_1 | 383 | 393 | PF00069 | 0.582 |
DOC_MAPK_MEF2A_6 | 315 | 324 | PF00069 | 0.375 |
DOC_PP1_RVXF_1 | 362 | 368 | PF00149 | 0.592 |
DOC_PP1_RVXF_1 | 71 | 78 | PF00149 | 0.280 |
DOC_PP2B_LxvP_1 | 247 | 250 | PF13499 | 0.305 |
DOC_PP2B_LxvP_1 | 276 | 279 | PF13499 | 0.401 |
DOC_PP2B_PxIxI_1 | 315 | 321 | PF00149 | 0.180 |
DOC_USP7_MATH_1 | 11 | 15 | PF00917 | 0.557 |
DOC_USP7_UBL2_3 | 398 | 402 | PF12436 | 0.735 |
DOC_WW_Pin1_4 | 211 | 216 | PF00397 | 0.294 |
DOC_WW_Pin1_4 | 3 | 8 | PF00397 | 0.515 |
LIG_14-3-3_CanoR_1 | 112 | 116 | PF00244 | 0.289 |
LIG_14-3-3_CanoR_1 | 167 | 173 | PF00244 | 0.304 |
LIG_14-3-3_CanoR_1 | 343 | 347 | PF00244 | 0.578 |
LIG_14-3-3_CanoR_1 | 354 | 360 | PF00244 | 0.587 |
LIG_14-3-3_CanoR_1 | 67 | 75 | PF00244 | 0.291 |
LIG_Actin_WH2_1 | 122 | 139 | PF00022 | 0.259 |
LIG_APCC_ABBA_1 | 320 | 325 | PF00400 | 0.368 |
LIG_BRCT_BRCA1_1 | 112 | 116 | PF00533 | 0.338 |
LIG_BRCT_BRCA1_1 | 381 | 385 | PF00533 | 0.596 |
LIG_deltaCOP1_diTrp_1 | 31 | 42 | PF00928 | 0.447 |
LIG_EH1_1 | 303 | 311 | PF00400 | 0.433 |
LIG_FHA_1 | 212 | 218 | PF00498 | 0.296 |
LIG_FHA_1 | 220 | 226 | PF00498 | 0.287 |
LIG_FHA_2 | 15 | 21 | PF00498 | 0.567 |
LIG_IRF3_LxIS_1 | 322 | 329 | PF10401 | 0.472 |
LIG_LIR_Gen_1 | 113 | 124 | PF02991 | 0.286 |
LIG_LIR_Gen_1 | 173 | 183 | PF02991 | 0.286 |
LIG_LIR_Gen_1 | 295 | 305 | PF02991 | 0.409 |
LIG_LIR_Gen_1 | 345 | 353 | PF02991 | 0.481 |
LIG_LIR_Gen_1 | 92 | 103 | PF02991 | 0.333 |
LIG_LIR_Nem_3 | 113 | 119 | PF02991 | 0.297 |
LIG_LIR_Nem_3 | 170 | 175 | PF02991 | 0.273 |
LIG_LIR_Nem_3 | 243 | 247 | PF02991 | 0.351 |
LIG_LIR_Nem_3 | 295 | 300 | PF02991 | 0.426 |
LIG_LIR_Nem_3 | 303 | 308 | PF02991 | 0.353 |
LIG_LIR_Nem_3 | 345 | 349 | PF02991 | 0.591 |
LIG_LIR_Nem_3 | 351 | 356 | PF02991 | 0.561 |
LIG_LIR_Nem_3 | 361 | 365 | PF02991 | 0.534 |
LIG_LIR_Nem_3 | 382 | 388 | PF02991 | 0.547 |
LIG_LIR_Nem_3 | 92 | 98 | PF02991 | 0.317 |
LIG_PCNA_yPIPBox_3 | 377 | 388 | PF02747 | 0.645 |
LIG_Pex14_1 | 47 | 51 | PF04695 | 0.271 |
LIG_Pex14_2 | 240 | 244 | PF04695 | 0.312 |
LIG_Pex14_2 | 48 | 52 | PF04695 | 0.335 |
LIG_SH2_CRK | 175 | 179 | PF00017 | 0.362 |
LIG_SH2_CRK | 255 | 259 | PF00017 | 0.380 |
LIG_SH2_CRK | 95 | 99 | PF00017 | 0.362 |
LIG_SH2_NCK_1 | 57 | 61 | PF00017 | 0.377 |
LIG_SH2_PTP2 | 313 | 316 | PF00017 | 0.410 |
LIG_SH2_PTP2 | 323 | 326 | PF00017 | 0.369 |
LIG_SH2_STAT5 | 124 | 127 | PF00017 | 0.274 |
LIG_SH2_STAT5 | 229 | 232 | PF00017 | 0.365 |
LIG_SH2_STAT5 | 269 | 272 | PF00017 | 0.320 |
LIG_SH2_STAT5 | 313 | 316 | PF00017 | 0.302 |
LIG_SH2_STAT5 | 323 | 326 | PF00017 | 0.347 |
LIG_SH2_STAT5 | 51 | 54 | PF00017 | 0.362 |
LIG_SH2_STAT5 | 69 | 72 | PF00017 | 0.362 |
LIG_SH3_3 | 189 | 195 | PF00018 | 0.280 |
LIG_SH3_3 | 236 | 242 | PF00018 | 0.390 |
LIG_SH3_3 | 384 | 390 | PF00018 | 0.594 |
LIG_SUMO_SIM_par_1 | 218 | 226 | PF11976 | 0.325 |
LIG_SUMO_SIM_par_1 | 355 | 361 | PF11976 | 0.588 |
LIG_TRAF2_1 | 373 | 376 | PF00917 | 0.655 |
LIG_TYR_ITIM | 55 | 60 | PF00017 | 0.294 |
LIG_UBA3_1 | 308 | 315 | PF00899 | 0.180 |
LIG_WRC_WIRS_1 | 169 | 174 | PF05994 | 0.362 |
MOD_CDK_SPK_2 | 211 | 216 | PF00069 | 0.320 |
MOD_CK1_1 | 138 | 144 | PF00069 | 0.169 |
MOD_CK1_1 | 14 | 20 | PF00069 | 0.490 |
MOD_CK1_1 | 170 | 176 | PF00069 | 0.361 |
MOD_CK1_1 | 211 | 217 | PF00069 | 0.340 |
MOD_CK1_1 | 358 | 364 | PF00069 | 0.573 |
MOD_CK1_1 | 369 | 375 | PF00069 | 0.612 |
MOD_CK1_1 | 379 | 385 | PF00069 | 0.611 |
MOD_CK1_1 | 396 | 402 | PF00069 | 0.662 |
MOD_CK2_1 | 197 | 203 | PF00069 | 0.362 |
MOD_CK2_1 | 293 | 299 | PF00069 | 0.431 |
MOD_CK2_1 | 369 | 375 | PF00069 | 0.671 |
MOD_Cter_Amidation | 399 | 402 | PF01082 | 0.522 |
MOD_Cter_Amidation | 71 | 74 | PF01082 | 0.491 |
MOD_GlcNHglycan | 104 | 107 | PF01048 | 0.501 |
MOD_GlcNHglycan | 150 | 153 | PF01048 | 0.562 |
MOD_GlcNHglycan | 225 | 228 | PF01048 | 0.528 |
MOD_GlcNHglycan | 271 | 274 | PF01048 | 0.569 |
MOD_GlcNHglycan | 61 | 64 | PF01048 | 0.517 |
MOD_GlcNHglycan | 80 | 83 | PF01048 | 0.377 |
MOD_GlcNHglycan | 91 | 94 | PF01048 | 0.471 |
MOD_GSK3_1 | 10 | 17 | PF00069 | 0.534 |
MOD_GSK3_1 | 131 | 138 | PF00069 | 0.169 |
MOD_GSK3_1 | 163 | 170 | PF00069 | 0.304 |
MOD_GSK3_1 | 178 | 185 | PF00069 | 0.257 |
MOD_GSK3_1 | 219 | 226 | PF00069 | 0.315 |
MOD_GSK3_1 | 36 | 43 | PF00069 | 0.326 |
MOD_GSK3_1 | 366 | 373 | PF00069 | 0.652 |
MOD_GSK3_1 | 85 | 92 | PF00069 | 0.313 |
MOD_N-GLC_1 | 211 | 216 | PF02516 | 0.562 |
MOD_NEK2_1 | 156 | 161 | PF00069 | 0.292 |
MOD_NEK2_1 | 168 | 173 | PF00069 | 0.324 |
MOD_NEK2_1 | 182 | 187 | PF00069 | 0.210 |
MOD_NEK2_1 | 326 | 331 | PF00069 | 0.413 |
MOD_NEK2_1 | 366 | 371 | PF00069 | 0.557 |
MOD_NEK2_1 | 393 | 398 | PF00069 | 0.673 |
MOD_NEK2_1 | 59 | 64 | PF00069 | 0.318 |
MOD_NEK2_1 | 85 | 90 | PF00069 | 0.317 |
MOD_NEK2_2 | 111 | 116 | PF00069 | 0.362 |
MOD_PKA_2 | 111 | 117 | PF00069 | 0.280 |
MOD_PKA_2 | 178 | 184 | PF00069 | 0.350 |
MOD_PKA_2 | 342 | 348 | PF00069 | 0.530 |
MOD_PKA_2 | 376 | 382 | PF00069 | 0.581 |
MOD_PKA_2 | 75 | 81 | PF00069 | 0.348 |
MOD_Plk_1 | 219 | 225 | PF00069 | 0.384 |
MOD_Plk_1 | 231 | 237 | PF00069 | 0.376 |
MOD_Plk_1 | 36 | 42 | PF00069 | 0.298 |
MOD_Plk_2-3 | 274 | 280 | PF00069 | 0.315 |
MOD_Plk_4 | 111 | 117 | PF00069 | 0.280 |
MOD_Plk_4 | 156 | 162 | PF00069 | 0.362 |
MOD_Plk_4 | 178 | 184 | PF00069 | 0.339 |
MOD_Plk_4 | 240 | 246 | PF00069 | 0.323 |
MOD_Plk_4 | 293 | 299 | PF00069 | 0.425 |
MOD_ProDKin_1 | 211 | 217 | PF00069 | 0.294 |
MOD_ProDKin_1 | 3 | 9 | PF00069 | 0.516 |
MOD_SUMO_for_1 | 196 | 199 | PF00179 | 0.362 |
TRG_DiLeu_BaEn_1 | 307 | 312 | PF01217 | 0.362 |
TRG_DiLeu_BaLyEn_6 | 164 | 169 | PF01217 | 0.354 |
TRG_DiLeu_BaLyEn_6 | 280 | 285 | PF01217 | 0.408 |
TRG_ENDOCYTIC_2 | 175 | 178 | PF00928 | 0.290 |
TRG_ENDOCYTIC_2 | 255 | 258 | PF00928 | 0.320 |
TRG_ENDOCYTIC_2 | 263 | 266 | PF00928 | 0.266 |
TRG_ENDOCYTIC_2 | 297 | 300 | PF00928 | 0.458 |
TRG_ENDOCYTIC_2 | 323 | 326 | PF00928 | 0.331 |
TRG_ENDOCYTIC_2 | 350 | 353 | PF00928 | 0.552 |
TRG_ENDOCYTIC_2 | 57 | 60 | PF00928 | 0.377 |
TRG_ENDOCYTIC_2 | 95 | 98 | PF00928 | 0.359 |
TRG_ER_diArg_1 | 119 | 122 | PF00400 | 0.221 |
TRG_ER_diArg_1 | 143 | 146 | PF00400 | 0.352 |
TRG_ER_diArg_1 | 235 | 238 | PF00400 | 0.395 |
TRG_ER_diArg_1 | 74 | 77 | PF00400 | 0.285 |
TRG_Pf-PMV_PEXEL_1 | 283 | 287 | PF00026 | 0.588 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P509 | Leptomonas seymouri | 73% | 94% |
A0A0S4IY58 | Bodo saltans | 35% | 100% |
A0A0S4J309 | Bodo saltans | 38% | 85% |
A0A1X0P9X6 | Trypanosomatidae | 44% | 100% |
A0A3S5H7X3 | Leishmania donovani | 91% | 93% |
A0A422N4J2 | Trypanosoma rangeli | 41% | 98% |
A4HB10 | Leishmania braziliensis | 79% | 100% |
A4IA67 | Leishmania infantum | 91% | 93% |
C9ZM39 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 41% | 100% |
Q4Q2Q3 | Leishmania major | 90% | 100% |
V5DLV7 | Trypanosoma cruzi | 41% | 97% |